Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Fierce Healthcare
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi
Jun 23, 2025 12:00pm
Lilly, Novo will be pharma sales leaders by 2030, Evaluate says
Jun 23, 2025 9:52am
AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia
Jun 20, 2025 11:28am
GLP-1 use in diabetes linked to possible eye disease risk: study
Jun 6, 2025 7:25am
Schott Pharma invests €100M in Hungary manufacturing expansion
Jun 5, 2025 9:40am
Novo's longtime CEO Lars Fruergaard Jørgensen to step down
May 16, 2025 9:41am